Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
interest in new biomolecular technologies. We teach bioinformatics courses across several programs within TU Delft and nationally, in which you will also assist. We value different perspectives and we
-
expertise, with a profound interest in new biomolecular technologies. We teach bioinformatics courses across several programs within TU Delft and nationally, in which you will also assist. We value different
-
for motivated individuals skilled in computer science/computational biology/bioinformatics with the desire to make a difference for people suffering from mental health problems. A Masters Degree in (Bio
-
., proteomics, lipidomics, small-molecule quantification), genomics, tissue culture, high-throughput drug screening, confocal microscopy, bioinformatics, and biostatistics. Biological sciences faculty maintain
-
., proteomics, lipidomics, small-molecule quantification), genomics, tissue culture, high-throughput drug screening, confocal microscopy, bioinformatics, and biostatistics. Biological Sciences faculty maintain
-
that the increased risk of UTIs observed in pregnancy may be in part due to differences in the types of E. coli causing the infections, including variations in phylogenetic group, virulence genes and antimicrobial
-
We are looking for a motivated and computationally interested student, to work in bioinformatic project on cutting-edge metagenomics and clinical translation. In the 4-year PhD project
-
innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top scientific research, we push back boundaries and
-
those using advanced AI, often fail to capture the nuanced clinical and social factors driving these differences, leading to inequitable health outcomes. This is largely because they struggle to leverage
-
connections to clinicians, patients, and European initiatives such as ERDERA. What sets us apart is our unique position at the interface of bioinformatics, clinical genetics, and patient care. This ensures